Applied Therapeutics Inc (APLT)
8.69
-0.32
(-3.55%)
USD |
NASDAQ |
Nov 15, 16:00
8.79
+0.10
(+1.15%)
After-Hours: 20:00
Applied Therapeutics Enterprise Value: 912.27M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 912.27M |
| November 14, 2024 | 949.51M |
| November 13, 2024 | 939.03M |
| November 12, 2024 | 1.053B |
| November 11, 2024 | 1.093B |
| November 08, 2024 | 1.075B |
| November 07, 2024 | 1.034B |
| November 06, 2024 | 1.024B |
| November 05, 2024 | 1.022B |
| November 04, 2024 | 978.59M |
| November 01, 2024 | 958.81M |
| October 31, 2024 | 929.72M |
| October 30, 2024 | 951.83M |
| October 29, 2024 | 919.25M |
| October 28, 2024 | 905.29M |
| October 25, 2024 | 882.02M |
| October 24, 2024 | 939.03M |
| October 23, 2024 | 944.85M |
| October 22, 2024 | 915.76M |
| October 21, 2024 | 947.18M |
| October 18, 2024 | 943.69M |
| October 17, 2024 | 905.29M |
| October 16, 2024 | 924.49M |
| October 15, 2024 | 964.63M |
| October 14, 2024 | 935.54M |
| Date | Value |
|---|---|
| October 11, 2024 | 898.31M |
| October 10, 2024 | 855.26M |
| October 09, 2024 | 856.42M |
| October 08, 2024 | 854.09M |
| October 07, 2024 | 797.08M |
| October 04, 2024 | 797.08M |
| October 03, 2024 | 816.28M |
| October 02, 2024 | 877.36M |
| October 01, 2024 | 877.36M |
| September 30, 2024 | 890.16M |
| September 27, 2024 | 827.58M |
| September 26, 2024 | 843.66M |
| September 25, 2024 | 840.22M |
| September 24, 2024 | 808.63M |
| September 23, 2024 | 759.82M |
| September 20, 2024 | 762.12M |
| September 19, 2024 | 796.57M |
| September 18, 2024 | 779.35M |
| September 17, 2024 | 411.84M |
| September 16, 2024 | 416.43M |
| September 13, 2024 | 439.40M |
| September 12, 2024 | 438.25M |
| September 11, 2024 | 476.15M |
| September 10, 2024 | 474.43M |
| September 09, 2024 | 539.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-41.24M
Minimum
Mar 14 2022
1.164B
Maximum
Feb 05 2020
298.49M
Average
287.82M
Median
Enterprise Value Benchmarks
| ResMed Inc | 34.71B |
| Axonics Inc | 3.283B |
| Organon & Co | 11.86B |
| NovaBay Pharmaceuticals Inc | 2.764M |
| Palatin Technologies Inc | 8.735M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -68.59M |
| Revenue (Quarterly) | 0.122M |
| Total Expenses (Quarterly) | 29.86M |
| EPS Diluted (Quarterly) | -0.48 |
| Profit Margin (Quarterly) | -56.22K% |
| Earnings Yield | -18.53% |
| Normalized Earnings Yield | -9.092 |